Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase NA 11Phase 3 4Phase 1/2 3Phase 1 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3Triple Negative Breast Neoplasms 1

Interventions

Trastuzumab 72Paclitaxel 63Cyclophosphamide 56pembrolizumab 52Fulvestrant 42Carboplatin 39Capecitabine 37Docetaxel 32Letrozole 27Doxorubicin 23palbociclib 21pertuzumab 20Nivolumab 18eribulin 17abemaciclib 17ribociclib 16Gemcitabine 16130-nm albumin-bound paclitaxel 16durvalumab 15Everolimus 15Albumin-Bound Paclitaxel 15sacituzumab govitecan 14Lapatinib 14Filgrastim 14fludarabine 13exemestane 13Taxes 13Bevacizumab 13Cisplatin 12olaparib 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Mastectomy × Breast × Clear all
NCT07217990 2026-02-17

NoCUT-BC

Ohio State University Comprehensive Cancer Center

Phase 1/2 Not yet recruiting
84 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00574587 2020-10-14

Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy

Albert Einstein College of Medicine

Phase 1/2 Completed
55 enrolled 10 charts
Breast

Breast Neoplasms

NCT00574301 2013-07-25

Percutaneous Removal and Margin Ablation for Breast Cancer

University of Arkansas

Phase 1/2 Completed
32 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡